Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Scott A Barman"'
Publikováno v:
Vascular Health and Risk Management, Vol 2009, Iss default, Pp 663-671 (2009)
Scott A Barman, Shu Zhu, Richard E WhiteDepartment of Pharmacology and Toxicology, Medical College of Georgia, Augusta, Georgia, USAAbstract: Pulmonary arterial hypertension (PAH) is a devastating disease characterized by progressive elevation of pul
Externí odkaz:
https://doaj.org/article/46a54fc22f5b4581afec0323ecf198df
Publikováno v:
Frontiers in Physiology, Vol 3 (2012)
The NADPH oxidase (Nox) family of proteins is comprised of 7 members, including Noxes 1-5 and the Duoxes 1 and 2. Nox4 is readily distinguished from the other Nox isoforms by its high level of expression in cardiovascular tissues and unique enzymatic
Externí odkaz:
https://doaj.org/article/9ed0a4907c914c52b4472a360f6d3c32
Autor:
Stephen Haigh, Zach L. Brown, Mitch A. Shivers, Hunter G. Sellers, Madison A. West, Scott A. Barman, David W. Stepp, Gabor Csanyi, David J. R. Fulton
Publikováno v:
Antioxidants, Vol 12, Iss 9, p 1689 (2023)
The detection of superoxide anion (O2●−) in biological tissues remains challenging. Barriers to convenient and reproducible measurements include expensive equipment, custom probes, and the need for high sensitivity and specificity. The luminol de
Externí odkaz:
https://doaj.org/article/0a9fab2f08ad48e9b3da209f3c6b8be7
Autor:
Robert K. Batori, Feng Chen, Zsuzsanna Bordan, Stephen Haigh, Yunchao Su, Alexander D. Verin, Scott A. Barman, David W. Stepp, Trinad Chakraborty, Rudolf Lucas, David J. R. Fulton
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Pneumolysin (PLY) is a bacterial pore forming toxin and primary virulence factor of Streptococcus pneumonia, a major cause of pneumonia. PLY binds cholesterol-rich domains of the endothelial cell (EC) plasma membrane resulting in pore assembly and in
Externí odkaz:
https://doaj.org/article/a855244bd2ed44449d1488efd66170f2
Autor:
Stephen Haigh, R. Daniel Rudic, Yusi Wang, Zsuzsanna Bordan, Feng Chen, Scott A. Barman, Keyvan Mahboubi, Xueyi Li, David Fulton
Publikováno v:
Antioxid Redox Signal
Significance: Pulmonary arterial hypertension (PAH) is a progressive disease arising from the narrowing of pulmonary arteries (PAs) resulting in high pulmonary arterial blood pressure and ultimately right ventricle (RV) failure. A defining characteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a2bedf871bd52276ed53c192e767526
https://doi.org/10.1089/ars.2019.7753
https://doi.org/10.1089/ars.2019.7753
Autor:
Yuqing Huo, Louise Meadows, Weihong Han, Scott A. Barman, Alexander D. Verin, Yunchao Su, Anita Kovacs-Kasa, Laszlo Kovacs, Dmitry Kondrikov, Yapeng Cao, Zheng Dong
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 200:617-627
Rationale: Glycolytic shift is implicated in the pathogenesis of pulmonary arterial hypertension (PAH). It remains unknown how glycolysis is increased and how increased glycolysis contributes to pulmonary vascular remodeling in PAH.Objectives: To det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ca094f3ba4c99ddd90afaa18a938f61
https://doi.org/10.1164/rccm.201812-2290oc
https://doi.org/10.1164/rccm.201812-2290oc
Autor:
Feng Chen, Keyvan Mahboubi, Daniel S. Weintraub, Peter Traber, Jennifer A. Thompson, Yusi Wang, Yunchao Su, Zsuzsanna Bordan, Jennifer C. Sullivan, G. Ryan Crislip, David J. Fulton, Stephen Haigh, Xueyi Li, Joshua T. Butcher, Jiliang Zhou, Danny Jonigk, David W. Stepp, William Snider, Dmitry Kondrikov, Scott A. Barman
Publikováno v:
Am J Physiol Lung Cell Mol Physiol
A defining characteristic of pulmonary hypertension (PH) is the extensive remodeling of pulmonary arteries (PAs), which results in progressive increases in vascular resistance and stiffness and eventual failure of the right ventricle. There is no cur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::260b88951e5d2e1ebdc7296f94d52187
https://doi.org/10.1152/ajplung.00186.2018
https://doi.org/10.1152/ajplung.00186.2018
Publikováno v:
Advances in experimental medicine and biology. 1303
Pulmonary Arterial Hypertension (PAH) is a progressive vascular disease arising from the narrowing of pulmonary arteries (PA) resulting in high pulmonary arterial blood pressure and ultimately right ventricular (RV) failure. A defining characteristic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::722e21dd96a2de964001118f9cd84a82
https://pubmed.ncbi.nlm.nih.gov/33788185
https://pubmed.ncbi.nlm.nih.gov/33788185
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783030630454
Pulmonary Arterial Hypertension (PAH) is a progressive vascular disease arising from the narrowing of pulmonary arteries (PA) resulting in high pulmonary arterial blood pressure and ultimately right ventricular (RV) failure. A defining characteristic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22de0ec4e5887cb20c840d77a1e476ea
https://doi.org/10.1007/978-3-030-63046-1_2
https://doi.org/10.1007/978-3-030-63046-1_2
Autor:
David J. Fulton, Yunchao Su, Qiuhua Yang, Lina Wang, Yapeng Cao, Mei Hong, Scott A. Barman, Zhiping Liu, Jiean Xu, Yuqing Huo, Qian Ma, Xiaoxiao Mao, Yaqi Zhou, Rudolf Lucas, Xiaoyu Zhang
Publikováno v:
British journal of pharmacologyREFERENCES. 178(5)
BACKGROUND AND PURPOSE Macrophage infiltration into the lungs is a characteristic of pulmonary hypertension (PH). Glycolysis is the main metabolic pathway for macrophage activation. However, the effect of macrophage glycolysis on the development of P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1809b9268a5bb285987280e54913ab3c
https://pubmed.ncbi.nlm.nih.gov/33300142
https://pubmed.ncbi.nlm.nih.gov/33300142